The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans about the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
赤裸裸的真相:通过纠正针对非裔美国人的关于 FDA 提议禁止薄荷卷烟和调味雪茄的虚假信息来追求健康公平
基本信息
- 批准号:10740281
- 负责人:
- 金额:$ 66.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-19 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT ABSTRACT
In April 2022, the U.S. Food and Drug Administration (FDA) announced a proposed ban on menthol cigarettes
and all characterizing flavors in cigars. African Americans have high rates of menthol cigarette and flavored cigar
use, which likely contributes to their disproportionate experience of tobacco-related health conditions. In
response to the FDA’s announcement, the tobacco industry and its sources promulgated disinformation in
African American communities about the increased criminalization and police discrimination for using tobacco
products when the rules are enforced. Although the FDA has stated that it cannot and will not enforce actions
against individual consumers for possessing or using menthol cigarettes or flavored cigars, disinformation about
the flavor ban and its harmful impacts continues spreading among African American communities. The proposed
study seeks to develop and evaluate the effectiveness of multi-level, anti-disinformation messages (ADM) to
disrupt the spread and mitigate the detrimental effects of disinformation about the FDA’s proposed ban on
menthol cigarettes and flavored cigars. In Aim 1, we will employ community-based participatory research
methods to develop and engage with an Expert Advisory Board (EAB) that will engage in shared decision-making
and provide their perspectives on all study activities. In Aim 2, we will conduct formative research to a)
characterize the tobacco industry and its operatives’ rhetoric about the consequences of the anticipated flavor
ban and b) elicit AA/Bs’ knowledge and perceptions about the anticipated flavor ban. Aim 2 data will inform the
development of the Intervention Mapping (IM) logic models that depict the behavioral and environmental risk
factors and determinants of respondents’ flavor ban receptivity. In Aim 3, we will use of IM process to develop,
pre-test, and refine the individual and community-level ADM and creative concepts among AA/B participants.
Finally, in Aim 4, we will conduct a randomized treatment and control evaluation design to test the effectiveness
of our individual and community-based ADM campaign on AA/Bs’ receptivity to the flavor ban and counter-
industry beliefs. Knowledge gained from this study will inform the FDA’s Center for Tobacco Products
Communication Office and state and local public health departments regarding salient messages to
communicate about the flavor ban to AA/B and other vulnerable populations.
项目摘要
2022年4月,美国食品药品监督管理局(FDA)宣布了拟议的禁止心态香烟的禁令
以及所有描述雪茄的口味。非洲裔美国人的香烟率很高,雪茄味
使用,这可能会导致他们在与烟草相关的健康状况方面的不成比例。在
对FDA公告,烟草业及其消息来源的回应爆发了
非裔美国人社区关于使用烟草的犯罪和警察歧视的增加
尽管FDA表示它不能也不会执行行动
反对个人消费者拥有或使用心态香烟或调味卷烟,对
风味禁令及其有害影响继续在非裔美国人社区中传播。提议
研究旨在开发和评估多层次,反分散信息(ADM)的有效性
破坏传播并减轻对FDA拟议禁令的虚假信息的有害影响
在AIM 1中,我们将采用基于社区的参与研究
开发和与专家顾问委员会(EAB)进行共同决策的方法
并提供他们对所有学习活动的看法。在AIM 2中,我们将对A进行形成性研究)
特征烟草业及其运营商对预期风味的后果的言论
禁令和b)引起了AA/BS对预期风味禁令的知识和看法。 AIM 2数据将告知
开发描述行为和环境风险的干预映射(IM)逻辑模型
因素并确定受访者的风味禁令识别。在AIM 3中,我们将使用IM流程来开发,
预测试,并在AA/B参与者中完善个人和社区级别的ADM和创造性概念。
最后,在AIM 4中,我们将进行随机治疗和控制评估设计以测试有效性
关于AA/BS接受风味禁令和反击的个人和社区的ADM运动
行业信念。从这项研究中获得的知识将为FDA烟草产品中心提供信息
通讯办公室以及州和地方公共卫生部门有关显着信息
与AA/B和其他弱势群体进行有关风味禁令的沟通。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Kymberle L Sterling其他文献
Assessing the Prevalence Rates of Internalizing Symptomatology Among Multiracial Adolescents in the United States: A Systematic Review.
评估美国多种族青少年内化症状的患病率:系统评价。
- DOI:
- 发表时间:20232023
- 期刊:
- 影响因子:2.9
- 作者:Mike Henson;S. Weerakoon;Chavonn Duncan;Taylor Choe;Ijeoma Opara;Kimberly A Baker;Kymberle L Sterling;Sarah E. MessiahMike Henson;S. Weerakoon;Chavonn Duncan;Taylor Choe;Ijeoma Opara;Kimberly A Baker;Kymberle L Sterling;Sarah E. Messiah
- 通讯作者:Sarah E. MessiahSarah E. Messiah
共 1 条
- 1
Kymberle L Sterlin...的其他基金
The C'RILLOS Project: Impact of Tobacco Regulatory Policy on Dynamic Use of Exclusive, Dual or Poly Cigar and Other Tobacco Product Use among Young Adults
CRILLOS 项目:烟草监管政策对年轻人动态使用单一雪茄、双雪茄或多聚雪茄和其他烟草产品的影响
- 批准号:1066606010666060
- 财政年份:2023
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Assessing Risk Perceptions of Flavored Small Cigars/Cigarillos Among Young Adults
评估年轻人对调味小雪茄/小雪茄的风险认知
- 批准号:86060628606062
- 财政年份:2013
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Assessing Risk Perceptions of Flavored Small Cigars/Cigarillos Among Young Adults
评估年轻人对调味小雪茄/小雪茄的风险认知
- 批准号:87378238737823
- 财政年份:2013
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Developing Measures of Little Cigar Use for Young Adults
制定年轻人吸少量雪茄的措施
- 批准号:85362458536245
- 财政年份:2012
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Developing Measures of Little Cigar Use for Young Adults
制定年轻人吸少量雪茄的措施
- 批准号:82596658259665
- 财政年份:2012
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:1074885910748859
- 财政年份:2024
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:1055811910558119
- 财政年份:2023
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Sleep and Cardiometabolic Subgroup Discovery and Risk Prediction in United States Adolescents and Young Adults: A Multi-Study Multi-Domain Analysis of NHANES and NSRR
美国青少年和年轻人的睡眠和心脏代谢亚组发现和风险预测:NHANES 和 NSRR 的多研究多领域分析
- 批准号:1063936010639360
- 财政年份:2023
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
- 批准号:1067955810679558
- 财政年份:2023
- 资助金额:$ 66.67万$ 66.67万
- 项目类别:
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
- 批准号:1064334410643344
- 财政年份:2023
- 资助金额:$ 66.67万$ 66.67万
- 项目类别: